VivoSeq
Other

Ibuprofen

0

Pipeline Programs↗

2

Active Trials↗

11

Companies Involved↗

Ibuprofen is an early-stage landscape with 0 programs across 11 companies. The most active players are Pfizer, Boehringer Ingelheim, Overseas Pharmaceuticals, Ltd..

Intelligence

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

90/100

Attrition Rate

7/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Pfizer logo

Pfizer

0 programs

PreclinicalBoehringer Ingelheim logo

Boehringer Ingelheim

0 programs

PreclinicalO

Overseas Pharmaceuticals, Ltd.

0 programs

PreclinicalB

Berlin-Chemie AG Menarini Group

0 programs

PreclinicalP

PLx Pharma

0 programs

PreclinicalI

Institut für Pharmakologie und Präventive Medizin

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

71

clinical trials

Completed55 · 77%
Unknown status8 · 11%
Terminated5 · 7%
Recruiting2 · 3%
Suspended1 · 1%

Clinical Trials

Trial Activity

71 trials

Precision Dosing of Oral Ibuprofen for PDA, A Pilot RCT
Recruiting·HHamilton Health Sciences Corporation·Phase 2·NCT07143201·26 enrolled
Treating Postictal Symptoms Using Ibuprofen and Nifedipine
Recruiting·UUniversity of Calgary·Phase 2·NCT03949478·90 enrolled
Bioequivalence Study Between Two Oral Formulations of Ibuprofen 800 mg Tablets Under Fed Conditions
Completed·PPerrigo Company·Phase 1·NCT00803946·30 enrolled
Self-Selection and Actual Use Trial of Ibuprofen 600 mg Immediate Release/Extended Caplet
Completed·Pfizer logoPfizer·Phase 3·NCT01789606·1,083 enrolled
Study Comparing the Efficacy of Two Ibuprofen Formulations
Completed·Pfizer logoPfizer·Phase 4·NCT00740857·211 enrolled
Safety of Ibuprofen After Major Orthopaedic Surgeries
Completed·NNaestved Hospital·Phase 4·NCT05575700·2,904 enrolled
Bioequivalence of a Fixed Dose Combination Tablet Containing 200 mg Ibuprofen and 30 mg Pseudoephedrine-HCl Compared to RhinAdvil(R)(200 mg Ibuprofen and 30 mg Pseudoephedrine-HCl) as a Fixed Dose Combination Tablet Administered in Healthy Volunteers.
Completed·Boehringer Ingelheim logoBoehringer Ingelheim·Phase 1·NCT01170637·47 enrolled
Bioequivalence of a Fixed Dose Combination Tablet Containing 400 mg Ibuprofen and 60 mg Pseudoephedrine-HCl Compared to Two Film Coated Fixed Dose Combination Tablets RhinAdvil(R)(200 mg Ibuprofen and 30 mg Pseudoephedrine-HCl) Administered in Healthy Subjects
Completed·Boehringer Ingelheim logoBoehringer Ingelheim·Phase 1·NCT02963701·56 enrolled
Adult Oral Ibuprofen Study for ED Pain Patients
Completed·—·Phase 4·NCT03441269·225 enrolled
Phase I Study to Evaluate the Safety of Dexibuprofen 200mg Under Fasting and Fed Conditions
Completed·—·Phase 1·NCT02956525·52 enrolled
Study of Ibuprofen Effects on Brain Function
Completed·LLaureate Institute for Brain Research, Inc.·Phase 2/3·NCT02507219·24 enrolled
Topical Ibuprofen for Delayed Onset Mulscle Soreness
Completed·Pfizer logoPfizer·Phase 3·NCT01794923·205 enrolled
Evaluation and Comparison of Systemic Exposure to Ibuprofen After Single Oromucosal Versus Oral Administrations
Completed·PPierre Fabre Medicament·Phase 1·NCT01859377·26 enrolled
A Bioequivalence Study Of Ibuprofen 50mg/ml (laboratórios Pfizer Ltda) In The Oral Suspension Form.
Completed·Pfizer logoPfizer·Phase 4·NCT01350596·24 enrolled
Ibuprofen Bioavailability Study
Completed·RReckitt Benckiser Healthcare (UK) Limited·Phase 1·NCT03180879·36 enrolled
Page 1 of 5

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)